163 results about "Medication taking" patented technology

The invention relates to the technical field of medical care data processing, and discloses a medical care data processing method and system based on artificial intelligence, and the method comprises the steps: recording a medicine taking moment, a medicine effect starting moment and a medicine effect ending moment when a user takes medicines of each dose type; executing a work intensity evaluation strategy for each time period, monitoring the typewriting frequency of the user in each time period, and calculating the work intensity of each time period according to the time period score of the user; according to historical workdays, executing a drug effect intensity matching strategy, and calculating the corresponding work intensity of the drugs of each dose category under the optimal work completion degree; executing an intelligent medicine taking time period matching strategy, and calculating the optimal medicine taking time and dosage type based on the predicted working intensity of the next workday; and a night dose intelligent back-pushing module is executed, the dose type of the medicine taken before sleep in the next workday is calculated, the matching degree between the medicine use and the work performance is improved, and the work efficiency and the state stability are maintained to the maximum extent.

The invention relates to an electronic liquid medicine cup with timing, quantitative and positioning functions, which comprises a cup body unit, and further comprises an authorized opening unit, a timing and quantitative positioning unit and a control unit, the quantitative dosing unit is used for outputting quantitative liquid medicine; the medicine receiving unit enables the liquid medicine flowing out of the liquid outlet to fall into the drinking cup under the action of gravity; a timing module and a voice module are integrated on the central control unit, and the central control unit is used for processing the identity information, controlling the cup cover to be opened and closed, managing the medicine taking time sequence and controlling the quantitative operation of the quantitative medicine feeding unit. The intelligent liquid medicine monitoring system has the advantages that a plurality of functional modules such as liquid storage, identity authentication (fingerprint identification), electric quantitative dosing (a power pump and a one-way valve), electromagnetic locking, remote communication, GPS positioning and man-machine interaction (a display screen) are highly integrated, and a complete intelligent liquid medicine monitoring scheme is formed; and full-process automatic management from reminding, authentication, taking to monitoring is realized.

The utility model provides an intelligent drug delivery machine, which belongs to the technical field of drug management and comprises a fixed box, bearing boxes fixedly connected to the tops of three sides of the fixed box respectively, drug feeding openings formed in the bottoms of the bearing boxes, observation windows formed in the inner surfaces of the bearing boxes and drug taking cabins formed in the tops of the three sides of the fixed box respectively. The signboard is fixedly mounted on the outer side of the medicine taking cabin; the medicine feeding mechanism comprises a medicine pushing assembly and a medicine distributing assembly which are matched to feed morning, noon and evening medicines into the corresponding medicine taking cabins according to time periods; the medicine pushing assembly comprises a servo motor installed on the outer side of the fixing box in a matched mode. Through the cooperation of the medicine pushing assembly and the medicine distributing assembly, it can be guaranteed that medicines in the morning, noon and evening are accurately pushed out to the designated medicine taking cabins every eight hours, medicine mixing is effectively prevented, leakage of redundant medicines can be prevented, and the effects that the medicine distributing accuracy is further guaranteed, and meanwhile the wrong medicine taking risk is reduced are achieved.

The application discloses a kind of solid teeth pain-relieving and inflammation-clearing traditional Chinese medicine composition, it is related to traditional Chinese medicine product technical field.The composition is composed of gypsum, raw rehmannia, coptis, talc, ocher, radix cyathulae and salvia miltiorrhiza seven raw medicinal materials, wherein gypsum, raw rehmannia are monarch drug, clear and purge stomach fire, cool blood and nourish yin;Coptis, talc are ministerial drug, clear heat and dry dampness, lead heat down;Ocher, radix cyathulae are auxiliary drug, heavy town counteract, lead fire down;Salvia miltiorrhiza is servant drug, promote blood circulation and remove blood stasis, promote tissue repair.Modern pharmacological research shows that each drug of the present party has the effects of anti-inflammatory, analgesic, antibacterial, improving microcirculation and protecting periodontal tissue etc.Clinical observation shows that the pain of most patients caused by stomach fire attacking upward, gum redness and swelling, burning pain, bleeding is significantly reduced after taking 1-2 doses, redness and swelling gradually subside.Compared with existing Chinese patent medicines, the present application is simple in prescription, low in cost, has the dual effects of rapid pain relief and long-term tooth fixation, and is especially suitable for patients with recurrent toothache and early periodontitis.

The invention discloses a medication management system with dose adjustment and a medication management method, and the method comprises the steps: enabling a doctor to give a medication scheme according to the illness state of a patient, update an individualized medication scheme according to a medication compliance report of the patient, and upload the medication scheme to a cloud server through the arrangement of a doctor terminal; and the cloud server sends a generated patient medication compliance report to a doctor end. The patient end confirms the medication scheme and generates a medication plan scheme according to the medication scheme; the intelligent medicine box controls the target medicine bin to discharge medicine according to the medicine taking scheme and the medicine taking plan scheme. Through cooperative work among the doctor end, the patient end and the intelligent medicine box, an individualized medicine taking scheme based on the doctor end is realized, and a patient can automatically execute a new medicine taking plan scheme and record medicine taking behaviors, so that dynamic dose control is realized in the medicine taking process of the patient, data interaction and medicine taking compliance feedback between the doctor and the patient are completed, and the patient can take medicine conveniently. The safety and the standardization of long-term medication of patients with chronic diseases are improved.

We provide a flexible, AI-powered wearable patch system for non-invasive medication compliance monitoring. [Solution] This system 100 integrates physiological sensors 101 to detect heart rate variability, skin temperature, electrocutaneous activity, and swallowing-related muscle signals. A drug detection sensor 102 identifies interactions with drug containers, and a medication event sensor 103 detects gestures or physiological signals indicating medication. An embedded AI processor 104 receives multimodal sensor data and performs digital filtering, normalization, artifact removal, and machine learning-based classification to determine medication confirmation events, missed doses, or irregular medication patterns. A power management unit 105 controls the power supply to ensure continuous operation. A wireless communication module 106 transmits processed medication data to an external device. This enables reliable, objective, and real-time medication confirmation without relying on invasive ingestion sensors or patient reports.

The invention relates to the technical field of medical treatment, in particular to a chronic infectious disease patient management system, which comprises a registration module used for registering identity information, body information, chronic infectious disease type information, chronic infectious disease condition information and other medical history information of a patient; the information database is used for storing disease condition characteristic data, historical treatment scheme data and precautions data of the chronic infectious diseases; the management platform comprises a doctor work station, a patient information station and a feedback module, and the doctor work station is used for obtaining cooperative information of a treatment scheme; the patient information station is used for generating a medicine taking scheme, a doctor seeing scheme and life precautions, and data of the patient information station is sent to the patient terminal, so that a patient obtains treatment and life related information; and the feedback module is used for inputting discomfort information of the patient. The treatment management efficiency of a hospital on the chronic infectious disease patient can be improved, and the chronic infectious disease patient can feed back own conditions in time.

The application discloses a sustained-release preparation of indobufen and a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations. The application relates to a sustained-release preparation of indobufen and a preparation method and application thereof. The preparation has the characteristics of stable sustained-release effect, high bioavailability, good drug-taking compliance and small side effect, and is suitable for the prevention and / or treatment of diseases such as ischemic cardiovascular diseases, ischemic cerebrovascular diseases and venous thrombosis.

The invention provides a multifunctional intelligent medicine box control method and system, and relates to the technical field of medical equipment. The method comprises the following steps: setting a medicine taking moment, at least one medicine taken at the same moment, and appearance description and taking items of the medicine; setting a storage partition of at least one medicine, and opening the storage partition; after the medicine is put into the storage subarea, medicine storage success is prompted; when the medicine taking moment arrives, medicine taking reminding information is broadcasted, a storage partition corresponding to the medicine taking moment is determined, and the storage partition is opened; acquiring a medicine box image after the storage partition is opened; determining medicine taking verification information; a medicine taking prompt message is generated and broadcasted; after the user completes medicine taking and inputs feedback information, the storage partition is closed. According to the method and the device, the medicine taking prompt message can be generated based on the medicine box image, medicine taking of the patient is verified through the medicine box image, the feedback information is collected after the user finishes medicine taking, the medicine taking accuracy and compliance are improved, and the medicine taking management efficiency is improved.

The application relates to the technical field of drug efficacy prediction, in particular to a multi-modal data prediction model for diabetes gene therapy response, which comprises an unmedicated data collection module, a medicated data collection module and a data prediction module.The unmedicated data collection module collects unmedicated data samples of a user; the medicated data collection module collects data samples of the user after taking medicine; the data samples comprise explicit data and implicit data; the explicit data is body information and medicine information related to blood glucose change; and the implicit data is blood glucose values corresponding to the explicit data; the data prediction module inputs fused features into a convolutional network model to generate drug efficacy prediction values.The application generates a prediction residual corresponding to the explicit data after taking medicine through a blood glucose value prediction module, identifies blood glucose fluctuation characteristics caused by non-drug factors by using the prediction residual, separates the net influence of medicine on blood glucose, and thus improves the accuracy of drug efficacy prediction.

The utility model discloses a medicine taking reminding device convenient to store medicine, which comprises a device main body, a display screen is arranged on the upper surface of the device main body and located in the front, keys are arranged on the upper surface of the device main body and located on one side of the display screen, and a medicine box is embedded in the rear end of the device main body. The surface of the medicine box is movably sleeved with a scraping sleeve, and a positioning piece is embedded in the upper surface of the scraping sleeve. According to the medicine taking reminding device facilitating medicine storage, after tablets in the medicine box are eaten up, the medicine box is taken out of the embedded groove, then the positioning piece is pulled upwards, the lower end of the positioning rod of the positioning piece is pulled out of the positioning groove of the medicine box, at the moment, the medicine box can be pushed, and the medicine box can be taken out conveniently. Due to the fact that the scraping sleeve can scrape and sweep the inner surface of the medicine box in the pushing process of the medicine box, medicine powder on the inner surface of the medicine box can be conveniently cleaned, and only part of the medicine powder attached to the surface of the scraping sleeve in the scraping and sweeping process needs to be cleaned.

The invention discloses a tacrolimus-containing pellet pharmaceutical composition, the pharmaceutical composition is composed of an enteric pellet and a sustained-release pellet, the enteric pellet comprises 0.5-5% of tacrolimus, 10-80% of a filler, 2-10% of a disintegrating agent, 1-5% of an adhesive, 0.5-2% of a flow aid, 0.5-1% of a lubricant, and 5-13% of an enteric coating material; the sustained-release pellet comprises 0.5 to 2% of tacrolimus, 10 to 80% of a filling agent, 2 to 10% of a disintegrating agent, 1 to 5% of an adhesive, 0.1 to 1% of a flow aid, 0.1 to 1% of a lubricant, 5 to 15% of a sustained-release coating material and 0.1 to 0.5% of a plasticizer. The pellet pharmaceutical composition containing tacrolimus disclosed by the invention can maintain longer blood concentration and longer action time, so that the medicine taking frequency is reduced, the compliance of a patient is improved, the toxic and side effects are reduced, and the effectiveness and safety of medicine use are further ensured.

The invention relates to the technical field of application of recuperating medicine boxes, in particular to a portable recuperating medicine box which comprises a tool storage layer and a medicine storage layer, the tool storage layer of the portable recuperating medicine box plays a role of a'logistics center 'in the recuperating medicine box, and tool grids and cup grooves are formed in the tool storage layer at the same time; the two requirements of'recuperating equipment 'and'medicine taking and water drinking' are integrated on the same horizontal level. The tool grid is a square deep cavity and exactly contains the tool carrying box, and the tool carrying box can be integrally drawn out and independently carried, so that required instruments only need to be placed in the box at one time before going out, repeated rummaging is not needed during subsequent multiple times of going out, and omission is avoided. The cup groove is located beside the tool grid, a user can directly take the cup and take medicine on the same side after completing operations such as blood pressure measurement and blood sugar measurement, the moving line is shortened, and the risk of instrument pollution caused by walking back and forth is reduced. Positioning sleeves are reserved at the four corners of the top face of the tool storage layer, and an inserting reference is provided for the upper medicine storage layer.

1. Name of this design product: Smart Vest for the Elderly. 2. Purpose of this design: To monitor the wearer's body temperature, heart rate, blood pressure, blood oxygen and other physical conditions, and to detect whether the wearer has fallen, as well as for wearing for warmth, emergency calls, and medication reminders. 3. The key design features of this product are the combination of shape and pattern. 4. The image or photograph that best illustrates the design's key points: a 3D model.

The invention relates to a preparation method and application of a suvortinib standard substance in human serum, and belongs to the field of medical examination. The standard substance is characterized by comprising the following three levels of suvaltinib solutions: a level 1: 10.00-50.00 [mu] g / L, a level 2: 10.00-50.00 [mu] g / L, and a level 3: 10.00-50.00 [mu] g / L; the level 2 is 450.00 to 750.00 [mu] g / L; the level is 3: 1200.00 to 2000.00 [mu] g / L; wherein the level 1 corresponds to the concentration range of the blood concentration trough of the suvortinib in the serum of a patient taking the medicine; the level 2 is an effective treatment blood concentration range; and the level 3 is the peak concentration range of the blood concentration. The standard substance can be used as a conventional detection limit and a reportable range of suvortinib in human serum. The standard substance has good uniformity, stability and interoperability, and can be applied to the fields of accuracy evaluation of blood concentration detection, detection result value traceability, performance evaluation of medical equipment, instrument calibration, research and development of medical equipment and the like.

The system provides medication guidance that allows patients to select and partially view videos of medication guidance they received from pharmacists at pharmacies, etc., using a terminal device operated by the patient. These selections should include specific items (e.g., dosage, timing of administration, warning signs, when to seek medical attention, etc.). [Solution] The server computer 105 generates tag information for each classified text data, which is created by classifying the audio text data obtained from the video data of medication guidance according to the content of the medication guidance. This tag information includes time information within the video and indicates the content of the guidance. When a patient obtains access information with the patient terminal device 201, multiple tag information linked to the video data indicated by that information is displayed on the terminal. When the patient taps the desired tag information, the video data for the corresponding section is played.

The application relates to an AI medical, nursing, health care and medicine management service system and a method thereof, and relates to the technical field of intelligent medical equipment and health management. The system comprises an intelligent terminal and a cloud data platform. The intelligent terminal is provided with a plurality of physically isolated and electrically independent intelligent medicine storage units. Each unit is provided with a lock control mechanism, a state indication component and a medicine taking sensing sensor. A master control unit sends an unlocking instruction at a preset medicine taking time and triggers an audible and light reminder. After an effective medicine taking signal is acquired through the medicine taking sensing sensor, behavior data containing a time stamp are generated and uploaded to the cloud, thereby forming a medicine taking behavior closed loop management mechanism. The application can realize forced verification and recording of medicine taking behavior, break the association link between health monitoring data and medicine taking records, and build a full-process family health management closed loop from reminding to replenishment.

The invention discloses a medicine taking state confirmation module, system and method, and the module comprises a triggering module which responds to the confirmation action that a user completes the medicine taking, and generates a triggering signal; the feedback module is used for providing a state feedback signal lasting for a preset duration under the control of the trigger signal; in the duration, the state feedback signal provides continuous visual feedback or interactive voice feedback, which indicates that the medicine taking behavior has occurred recently. The medicine taking state confirmation system integrates the modules and can be a medicine integrated system, an intelligent medicine box integrated system, a mobile terminal integrated system, a wearable device integrated system, an intelligent loudspeaker box integrated system, an intelligent camera integrated system or a cooperative system. According to the invention, through the'trigger-feedback 'closed-loop logic, the one-time medicine taking action is converted into the state feedback signal lasting for the preset duration, so that the situations of repeated medicine taking and missing medicine taking are effectively prevented, and the problems of confirmation and tracing of medicine taking behaviors are solved.

A health analysis system and method configured to base sensor measurements on detection of ingestion of a medication by a patient. The health analysis system receives an indicator collected by a first sensor associated to the patient. The indicator identifies a first adherence event at a first indicator time indicating at least a first medication was ingested by the patient. In response to detection of the indicator, first physiological data of the patient is received which was collected by a second sensor. A first wellness indicator is predicted based on the first physiological data of the patient.

The application discloses a kind of radioactive medicament subpackaging system and method, the system includes medicament storage tank and medicine cup, medicament storage tank is equipped with dosing port, water inlet, air inlet and dosing port, air inlet is connected air pump by air inlet pipe;Medicament storage tank top is equipped with ultrasonic liquid level meter and plastic flash detector, and the measuring head of ultrasonic liquid level meter and the detection head of plastic flash detector are inserted into medicament storage tank;It also includes Geiger counter, main control module, display module and power module, and the medical radioisotope database is stored in main control module;Ultrasonic liquid level meter, plastic flash detector and Geiger counter are connected with main control module, to transmit measured data to main control module, main control template and air pump are connected;Dosing port is equipped with electromagnetic valve, main control template and electromagnetic valve are connected, to control dosing amount by ultrasonic liquid level meter feedback signal real-time control electromagnetic valve.The application can effectively guarantee the uniformity of radioactive medicament dilution, improve the precision of patient dosage.

The application belongs to the technical field of pharmaceutical preparations, and discloses a soft capsule preparation containing alfacalcidol and a preparation method thereof. The soft capsule preparation comprises a soft capsule shell and content filled in the soft capsule shell, and the content is composed of a drug-containing oil phase and alfacalcidol sustained-release pellets dispersed in the oil phase. The drug-containing oil phase comprises immediate-release alfacalcidol dissolved in an oily base. The sustained-release pellets comprise a blank pellet core, a drug-loaded layer and a separation layer, and the separation layer comprises a combined coating material of Eudragit RS30D and Eudragit RL30D. After oral administration, the alfacalcidol in the oil phase is rapidly released to achieve immediate effect, and the alfacalcidol in the sustained-release pellets is slowly released to maintain the steady state of blood drug concentration. The soft capsule preparation of the application realizes the dual-phase drug release behavior of immediate release and sustained release in the same soft capsule, so that the blood drug concentration is smooth and controllable within 24 hours, the steady state of blood drug concentration is maintained, the frequency of drug administration is reduced, and the risk of side effects such as hypercalcemia is reduced.

The invention relates to the technical field of intelligent wearable equipment, in particular to a flexible compartment type health linkage bracelet with a medicine taking reminding function, which comprises a bracelet body, a medicine storage module used for storing medicine and a medicine taking reminding module used for reminding a patient to take medicine are installed in the bracelet body, and a solvent tablet rolling module connected with the bracelet body is arranged above the medicine storage module. The periphery of the bracelet body is also provided with a warning lamp for flickering to remind a patient to take medicine; watchbands are installed on the two sides of the bracelet body, and inflatable air bags are embedded in the inner sides of the watchbands. In the medicine taking process, once no water exists, the degradable first high-hydrophilicity gel coating and the degradable second high-hydrophilicity gel coating are arranged in the medicine bin on one side, the tablets make contact with the first high-hydrophilicity gel coating and the second high-hydrophilicity gel coating at the position and are attached to the surfaces of the medicines, the tablets are rapidly dissolved to form a lubricating film after meeting saliva, the esophageal adhesion risk is reduced, extra water does not need to be added, and the medicine taking cost is reduced. The medicine can be smoothly swallowed through saliva and gel lubrication, and esophagitis and throat blockage caused by dry swallowing are avoided.

The application provides oseltamivir tablets and a preparation method, the oseltamivir tablets comprising, in terms of weight fractions, 230-250 parts of sustained-release granules, 45-65 parts of immediate-release granules, 10-20 parts of a glidant, and 20-30 parts of a binder, wherein the sustained-release granules contain 110-130 parts of oseltamivir free base, and the immediate-release granules contain 25-35 parts of oseltamivir free base.The oseltamivir tablets have a small single tablet weight and good sustained-release effect, and the patient's medication compliance is strong; by optimizing the particle size and preparation process of the immediate-release granules to reduce the deviation of the initial dissolution rate, the drug quality is controllable and the drug efficacy is stable.

The invention relates to an intelligent management system and method for self-contained medicines of inpatients in a specialized hospital. A self-contained medicine registration module is used for registering inpatient information and respective medicine preparation information of the inpatients; the medicine taking execution recording module generates a daily medicine taking task of the inpatient according to the self-contained medicine doctor's advice information, and when abnormity occurs, the abnormity recording module is called for recording and then receives a confirmation operation for determining whether the daily medicine taking task of the inpatient is completed or not; the dynamic inventory monitoring module tracks and displays the respective medicine preparation inventory information of the inpatient in real time, updates the respective medicine preparation inventory information of the inpatient by considering the daily medicine taking task, the actual remaining inventory and abnormal information when the completion confirmation operation is received, and updates the respective medicine preparation inventory information of the inpatient when the uncompleted confirmation operation is received. The daily medicine taking task, the actual remaining stock and the abnormal information are used for updating the respective medicine preparation stock information of the hospitalized patient, after updating, it is analyzed that the stock information of a certain self-prepared medicine reaches the stock early warning condition, and reminding information that the stock of the self-prepared medicine of the hospitalized patient is insufficient and needs to be supplemented is sent out.

The invention relates to the technical field of drug effect prediction, in particular to a multi-modal data prediction model for diabetes gene therapy response, which comprises an untaken medicine data acquisition module for acquiring a data sample of untaken medicine of a user; the medicine taking data acquisition module is used for acquiring data samples after the user takes medicine, the data samples comprise dominant data and recessive data, the dominant data are body information and medicine taking information related to blood glucose changes, and the recessive data are blood glucose values corresponding to the dominant data; and the data prediction module inputs the fusion features into a convolutional network model to generate a drug effect prediction value. The prediction residual error corresponding to the dominant data after medicine taking is generated through the blood glucose value prediction module, the blood glucose fluctuation characteristic caused by non-medicine factors is recognized through the prediction residual error, the net influence effect of the medicine on blood glucose is separated, and therefore the medicine effect prediction accuracy is improved.

The present application provides a glucose sustained-release suspension which improves the oral sensation and increases the compliance of patients, especially children, by using a special prescription of smooth excipients.

It provides a simple and self-contained medication management system that ensures medication is taken as prescribed and prevents missed doses by utilizing built-in reminders and medication verification functions, without relying on external servers or devices. The present invention provides a medication management system having the following configuration: a pocket (4) arranged in 4 rows and 7 columns on the surface of a main body (1), an LED (3) for notifying the scheduled medication, a liquid crystal display (LCD) (6), a confirmation button (5) for confirming medication, a buzzer (2) for voice notification, an SD card reader (7) for storing data, and an RTC module (12) for time management. In addition, a control and communication module is built-in, enabling the management of medication schedules and the transmission of notifications via the Internet. By doing so, a simple and practical system that supports patient compliance with medication is realized.

The application discloses a kind of intelligent warehouse distribution and compliance management system and method for chronic medication, belong to the field of wisdom medical technology.System includes cloud platform, intelligent warehouse terminal, modular intelligent medicine box, wearable device and unmanned distribution terminal.Method is: cloud is through LSTM-Transformer hybrid network prediction patient future probability of missing and position trajectory, dynamically triggers warehouse terminal according to single dose encapsulation sub-warehouse;Distribution engine assigns unmanned terminal to advance sub-warehouse to patient predicted stop point;Intelligent medicine box combines weighing difference, swallowing sound identification, laryngeal movement and other multi-modal signals to make decision fusion, confirm real medicine taking and feedback optimization model.The application realizes the active warehouse distribution driven by prediction and multi-modal medicine taking confirmation closed loop, fundamentally solves the problem of missing and false compliance caused by going out etc., with intelligent, individualization and self-evolution ability.

This invention discloses a medication adherence prediction and assessment system for patients with chronic diseases, relating to the field of chronic disease management technology. The system includes: a data acquisition module that collects patients' medication behavior and treatment effect data; a behavior adherence calculation module and an effect adherence calculation module that calculate behavior adherence scores reflecting the degree to which medication behavior conforms to the plan and effect adherence scores reflecting the degree to which treatment effects are achieved, respectively; a contribution confidence calculation module that couples the above adherence scores to obtain a contribution confidence score characterizing the credibility of the behavior's contribution to the effect; an overall adherence assessment module that makes dynamic decisions based on this: high-confidence drugs are directly included in the calculation, low-confidence drugs are excluded, and medium-confidence drugs are included after weight adjustment; and a result output module that generates a medication adherence assessment result based on weighted calculation. This invention can effectively improve the accuracy of the assessment.

A pill case and medication reminder system is provided. A pill case and a reminder system are in data transfer communication with one another. The system can also include a global positioning system, an accelerometer, or both. A pill case compartment is configured to hold a medication. The pill case has a sensor or sensor array configured to detect the amount of medication in the pill case. A pill case processor is configured to generate a data signal pertaining to the amount of medication in the pill case. The system can generate medication reminders, for example, pertaining to refilling a subscription or taking medication with food. The pill case can include or connect to a phone case for a smartphone, or can be integrated into a smartwatch.